Purchase Order 75N93020P00115

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to EMD Millipore Corp for $12,906.00 on December 13, 2018, for essential service for Erenna instrumentation. Place of performance is North Bethesda, Maryland. The order carries firm fixed price pricing with an ultimate completion date of November 30, 2019. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to EMD Millipore Corp for $8,577.00 on May 11, 2018, with final completion by August 31, 2018. The order covers relocation of an Erenna instrument from Building 40 to 9 West Watkins Mill Road in Gaithersburg, Maryland. Pricing is firm fixed price; no set-aside applies.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to EMD Millipore Corp on September 10, 2020, for $13,807.60 under firm fixed price terms. Work is performed in Burlington, Massachusetts. The order is not set-aside and carries an ultimate completion date of September 30, 2020.</p>

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $170,730 firm fixed price purchase order to EMD Millipore Corporation for the supply of Millipore-Sigma laboratory supplies and consumables. Per the original solicitation, EMD Millipore will provide Millipore-Sigma brand products including laboratory supplies, consumables, and their delivery in accordance with the attached bill of materials. The contract...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to EMD Millipore Corporation, a foreign-owned for-profit manufacturer of laboratory products and services, for an xMap Intelliflex Protein Analyte Detection System and related installation and software. The total potential value of the contract is $105,485.00. The contract has a completion date of August 22, 2023 and was awarded...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to EMD Millipore Corp on March 26, 2018, for a MILLIPLEX Non-Human Primate Cytokine/Chemokine Panel 1 Premixed 23-Plex assay kit with a ceiling value of $8,669.25. Performance is located in Bethesda, Maryland. The order was firm fixed price with an ultimate completion date of April 22, 2018.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to EMD Millipore Corp on August 27, 2021, for $10,575.80 to procure a MILLIPLEX MAP non-human primate cytokine magnetic bead panel—premixed 23-plex immunology multiplex assay. The order was issued as a firm fixed price procurement with no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order has an ultimate completion date of November 29, 2022, and was issued to de-obligate expiring...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $10,988 firm fixed-price purchase order to EMD Millipore Corp, also known as EMD Millipore Corporation and Milliporesigma, for the Millipore NHP 23-Plex Array. This order was not designated as a set-aside contract. EMD Millipore Corp is a foreign-owned, for-profit manufacturer that provides a wide range of laboratory products and services to federal agencies. The...

This is a federal contract award to EMD Millipore Corp, a foreign-owned, for-profit manufacturer, by the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH). The contract has a ceiling value of $5,559.60 and is for the procurement of an unspecified &quot;ASSAY&quot; product or service. The contract is a firm fixed-price purchase order with no set-aside designation. EMD Millipore Corp provides a wide range of laboratory products and services...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to EMD Millipore Corp for a non-human primate cytokine/chemokine panel on May 15, 2018, with a firm fixed price ceiling value of $8,669.25. Place of performance is Burlington, Massachusetts. No small business set-aside was applied.</p>